https://www.selleckchem.com/products/U0126.html
Better PROMIS Pediatric scores were associated with lower disease activity, in both cross-sectional and longitudinal analyses. For a change from moderate/severe to remission, observed effect estimates were -5.1 points for anxiety, -5.0 for depressive symptoms, -14.7 for pain interference, -13.7 for fatigue, and 5.3 for peer relationships (P 0.05 for all domains). Better PROMIS Pediatric scores were associated with improved IMPACT-III scores (P values 0.01), and changes in scores were moderately correlated with changes in IMPACT-I
Like
Comment
Share
